[su_accordion]
[su_accordion]
[su_spoiler title="Real world evidence on the disparities in prescribing of dipeptidyl peptidase-4 inhibitors in UK primary care" style="fancy"]
[su_button url="https://orchid.phc.ox.ac.uk/wp-content/uploads/2016/05/duk16_poster_dpp4_prescribing_trends.pdf" target=blank" icon="icon: arrow-circle-down"]Download PDF[/su_button] [/su_spoiler] [su_spoiler title="Real world evidence on the prescribing trends of glucagon-like peptide-1 agonists in UK primary care" style="fancy"]
[su_button url="https://orchid.phc.ox.ac.uk/wp-content/uploads/2016/05/duk16_poster_glp1_prescribing_trends.pdf" target=blank" icon="icon: arrow-circle-down"]Download PDF[/su_button] [/su_spoiler] [su_spoiler title="Real world evidence on the prescribing trends in sodium glucose co-transporter 2 inhibitors in UK primary care" style="fancy"]
[su_button url="https://orchid.phc.ox.ac.uk/wp-content/uploads/2016/05/duk16_poster_sglt2_prescribing_trends.pdf" target=blank" icon="icon: arrow-circle-down"]Download PDF[/su_button] [/su_spoiler] [/su_accordion]